These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9809214)

  • 21. Are there differences by gender in response to pharmacotherapy for depression?
    Marsland TW; Newton W
    J Fam Pract; 2000 Dec; 49(12):1149. PubMed ID: 11132066
    [No Abstract]   [Full Text] [Related]  

  • 22. Bupropion for SSRI-induced fatigue.
    Green TR
    J Clin Psychiatry; 1997 Apr; 58(4):174. PubMed ID: 9164429
    [No Abstract]   [Full Text] [Related]  

  • 23. L-Acetylcarnitine in dysthymic disorder in elderly patients: a double-blind, multicenter, controlled randomized study vs. fluoxetine.
    Bersani G; Meco G; Denaro A; Liberati D; Colletti C; Nicolai R; Bersani FS; Koverech A
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1219-25. PubMed ID: 23428336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.
    Bodkin JA; Lasser RA; Wines JD; Gardner DM; Baldessarini RJ
    J Clin Psychiatry; 1997 Apr; 58(4):137-45. PubMed ID: 9164423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SSRI-associated sexual dysfunction.
    Balon R
    Am J Psychiatry; 2006 Sep; 163(9):1504-9; quiz 1664. PubMed ID: 16946173
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of dysthymia.
    Buni TM
    J Fam Pract; 1997 Jun; 44(6):528-9. PubMed ID: 9191617
    [No Abstract]   [Full Text] [Related]  

  • 27. An open treatment trial of venlafaxine for elderly patients with dysthymic disorder.
    Devanand DP; Juszczak N; Nobler MS; Turret N; Fitzsimons L; Sackeim HA; Roose SP
    J Geriatr Psychiatry Neurol; 2004 Dec; 17(4):219-24. PubMed ID: 15533993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Potentialities of treating secondary dysthymia with painful dysfunction of temporomandibular joint].
    Gorozhankina EA; Markov BP; Mamedov FM
    Stomatologiia (Mosk); 2003; 82(5):44-7. PubMed ID: 14608350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.
    Ravindran AV; Guelfi JD; Lane RM; Cassano GB
    J Clin Psychiatry; 2000 Nov; 61(11):821-7. PubMed ID: 11105734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symptom remission in OCD after discontinuation of pharmacotherapy with fluoxetine: a case for looking beyond serotonin.
    Zurowski B; Wahl K; Hohagen F; Kordon A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):959-60. PubMed ID: 17321024
    [No Abstract]   [Full Text] [Related]  

  • 31. Risperidone and fluoxetine in the treatment of pedophilia with comorbid dysthymia.
    Bourgeois JA; Klein M
    J Clin Psychopharmacol; 1996 Jun; 16(3):257-8. PubMed ID: 8784662
    [No Abstract]   [Full Text] [Related]  

  • 32. Adding group psychotherapy to medication treatment in dysthymia: a randomized prospective pilot study.
    Hellerstein DJ; Little SA; Samstag LW; Batchelder S; Muran JC; Fedak M; Kreditor D; Rosenthal RN; Winston A
    J Psychother Pract Res; 2001; 10(2):93-103. PubMed ID: 11264333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and treatment of dysthymia in children and adolescents.
    Nobile M; Cataldo GM; Marino C; Molteni M
    CNS Drugs; 2003; 17(13):927-46. PubMed ID: 14533944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychotherapy for chronic major depression and dysthymia: a meta-analysis.
    Cuijpers P; van Straten A; Schuurmans J; van Oppen P; Hollon SD; Andersson G
    Clin Psychol Rev; 2010 Feb; 30(1):51-62. PubMed ID: 19781837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orphan comparisons and indirect meta-analysis: a case study on antidepressant efficacy in dysthymia comparing tricyclic antidepressants, selective serotonin reuptake inhibitors, and monoamine oxidase inhibitors by using general linear models.
    Ballesteros J
    J Clin Psychopharmacol; 2005 Apr; 25(2):127-31. PubMed ID: 15738743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis.
    Cuijpers P; Dekker J; Hollon SD; Andersson G
    J Clin Psychiatry; 2009 Sep; 70(9):1219-29. PubMed ID: 19818243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoxetine discontinuation in elderly dysthymic patients.
    Devanand DP; Kim MK; Nobler MS
    Am J Geriatr Psychiatry; 1997; 5(1):83-7. PubMed ID: 9169249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ruminative coping among patients with dysthymia before and after pharmacotherapy.
    Kelly O; Matheson K; Ravindran A; Merali Z; Anisman H
    Depress Anxiety; 2007; 24(4):233-43. PubMed ID: 17004237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Venlafaxine-associated mania.
    Shulman RB; Scheftner WA; Nayudu S
    J Clin Psychopharmacol; 2001 Apr; 21(2):239-41. PubMed ID: 11270924
    [No Abstract]   [Full Text] [Related]  

  • 40. Psychogenic itch responding to topiramate.
    Calabrò RS; Bramanti P; Digangi G; Mondello S; Italiano D
    Psychosomatics; 2013; 54(3):297-300. PubMed ID: 23274005
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.